https://www.fiercebiotech.com/medtech/ai-drug-designer-insilico-medicine-aims-generate-300m-hong-kong-ipo?utm_source=tldrbio.tech&utm_medium=referral&utm_campaign=biotech-pharma-updates-december-17-18-2025
The IPO wraps up a year that saw Insilico raise $110 million in venture capital and sign multiple R&D deals with global drugmakers.
insilico medicineaidrugdesignerhong